Skip to main content
Premium Trial:

Request an Annual Quote

Minerva Biolabs Licenses DxS Genotyping System for SARS Diagnostic Development

NEW YORK, June 17 - DxS of Manchester, UK, said today that it has signed a license agreement for its Scorpions PCR-based genotyping technology with Minerva Biolabs of Berlin.

 

Minerva will use the fluorescence-based nucleic acid detection system in its development of a real-time PCR diagnostic test for the SARS virus. The molecular diagnostics firm has already developed Scorpions-based diagnostics for Legionella and Mycoplasma.

 

Steve Little, DxS CEO, said the company is "currently in discussion with a number of other international diagnostics companies with regards to technology licenses in addition to continuing to build our genotyping services business."

 

DxS said that Scorpions is also non-exclusively licensed to Ortho-Clinical Diagnostics in the field of oncology and to a number of oligonucleotide manufacturers.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.